What to Avoid When Taking Sunosi (Solriamfetol)

The Most Dangerous Combination: MAO Inhibitors

If there is one interaction every person taking solriamfetol must know, it is the absolute contraindication with monoamine oxidase inhibitors, commonly called MAOIs. This category includes medications like phenelzine, tranylcypromine, selegiline, and even linezolid, an antibiotic that carries MAOI-like properties.

Combining solriamfetol with an MAOI can trigger a hypertensive crisis, a sudden and potentially life-threatening spike in blood pressure. This is not a dose-dependent risk that can be managed by taking less of each drug. It is a pharmacological conflict serious enough to appear as a contraindication in the official prescribing information.

The required safety buffer is a 14-day washout period after stopping any MAOI before beginning solriamfetol. Patients who have recently been treated for depression or Parkinson's disease should specifically confirm with their prescriber whether any MAOI was part of their regimen, since these drugs are used in both conditions and are sometimes prescribed under names patients may not immediately recognize.

Other Medications That Raise Serious Concern

Beyond MAOIs, a broader set of medications can interact with solriamfetol in ways that amplify cardiovascular stress or produce unpredictable effects.

Dopaminergic drugs such as bupropion, which is used for both depression and smoking cessation, can compound the stimulant load because solriamfetol itself works by inhibiting the reuptake of dopamine and norepinephrine. Sympathomimetic agents, including over-the-counter decongestants like pseudoephedrine, may further elevate heart rate and blood pressure when layered on top of solriamfetol's effects.

Opioid medications present a different kind of concern. Their interaction with solriamfetol's mechanism is less predictable, and combining them may produce outcomes that are difficult to anticipate based on either drug alone. Patients who take stimulant medications for ADHD should also raise this with their prescriber, since using two wakefulness-promoting agents together warrants careful monitoring.

Stimulant Substances Often Overlooked

Prescription drugs are not the only stimulant sources that interact with solriamfetol. Everyday products and supplements can quietly add to the drug's cardiovascular burden in ways patients may not anticipate.

Caffeine from coffee, tea, energy drinks, and pre-workout supplements stacks directly on top of solriamfetol's wakefulness mechanism. The combined stimulant load can increase the risk of palpitations, anxiety, insomnia, and elevated blood pressure, particularly in people who are already sensitive to either substance.

Over-the-counter weight loss products deserve special attention because they frequently contain stimulant compounds like synephrine that are not always listed prominently. Herbal supplements including ginseng and guarana are similarly easy to overlook, yet both carry stimulant properties that may interact with solriamfetol.

Alcohol, Cannabis, and Sedating Substances

Alcohol does not directly neutralize solriamfetol, but its effects can still cause problems. Regular alcohol use adds cardiovascular strain and undermines the sleep architecture that solriamfetol is meant to help stabilize. From a clinical standpoint, alcohol also makes it harder for both the patient and the prescriber to assess whether the medication is actually working.

Sedating antihistamines, whether used for allergies or as sleep aids, may blunt the drug's intended effect and complicate symptom tracking. Benzodiazepines and other sleep aids used alongside solriamfetol may mask the true severity of an underlying sleep disorder, which can delay appropriate treatment adjustments. These combinations are worth discussing with a prescriber rather than managing independently.

Cannabis, particularly products with high THC content, can raise heart rate in ways that are difficult to predict when a stimulant agent is already active in the body. Patients using cannabis regularly should disclose this when being evaluated for solriamfetol treatment.

Timing and Behavioral Mistakes That Undermine Safety

Some of the most common problems with solriamfetol are not about drug interactions at all. They are behavioral patterns that patients have direct control over.

Taking the drug too late in the day is probably the most frequent and most preventable issue. Because solriamfetol is designed to promote wakefulness, an afternoon or evening dose can cause significant difficulty falling asleep at night, which in turn worsens the sleep disorder the medication is meant to treat.

Skipping a dose and then doubling up the next day is not a safe recovery strategy and is not supported by prescribing guidance. Abruptly stopping the medication without prescriber input can trigger rebound excessive sleepiness, which may be disorienting and potentially hazardous depending on a patient's daily responsibilities.

Patients who do not establish a baseline awareness of their resting heart rate and blood pressure before starting solriamfetol may have difficulty detecting early cardiovascular side effects, since they lack a reference point for comparison.

Patient Factors That Change the Risk Profile

Certain health conditions and personal histories elevate the baseline risk of taking solriamfetol in ways that should directly shape how the drug is prescribed and monitored.

Patients with pre-existing hypertension, heart arrhythmias, or structural cardiac disease face heightened cardiovascular risk. A monitoring plan that tracks blood pressure and heart rate during treatment is especially important for this group.

Severe renal impairment reduces the body's ability to clear solriamfetol, meaning a standard dose may effectively accumulate to a higher concentration than intended. Dose adjustment is necessary in this population, and treatment without accounting for kidney function could increase side effect risk substantially.

Solriamfetol is classified as a Schedule IV controlled substance, which means a history of substance use disorder is a clinically relevant factor in prescribing decisions. This is not a disqualifying detail in every case, but it is information a prescriber needs to weigh thoughtfully. Finally, patients who are pregnant or breastfeeding must disclose this before starting treatment, since safety data in these populations remains limited.

Frequently Asked Questions

Can you drink alcohol while taking Sunosi (solriamfetol)?

Alcohol does not directly cancel out solriamfetol, but it can worsen cardiovascular strain and disrupt the sleep cycle the medication is designed to support. Regular or heavy alcohol use may also make it harder for your prescriber to accurately assess how well the drug is working for your sleep disorder.

What medications cannot be taken with solriamfetol?

MAO inhibitors are strictly contraindicated and require a 14-day washout period before starting solriamfetol. Other medications that may create serious risk include dopaminergic drugs like bupropion, sympathomimetic agents such as pseudoephedrine, opioids, and other stimulant medications. Always share your full medication list with your prescriber before starting Sunosi.

Can I take solriamfetol with Adderall or other ADHD stimulants?

Combining solriamfetol with ADHD stimulants like Adderall is not generally recommended without close prescriber oversight. Both medications affect cardiovascular function and can compound risks like elevated heart rate, high blood pressure, and insomnia. Patients currently on ADHD medication should flag this before receiving a Sunosi prescription.

What happens if you take solriamfetol too late in the day?

Taking solriamfetol in the afternoon or evening is a common mistake that can cause significant difficulty falling asleep at night. Because the drug is designed to promote wakefulness, most prescribers recommend taking it in the morning shortly after waking. Following the recommended timing closely helps avoid unnecessary sleep disruption.

Is it safe to drink coffee while on Sunosi?

Coffee and other caffeine sources are not strictly forbidden, but they add to solriamfetol's stimulant load. This combination may increase the risk of palpitations, anxiety, elevated blood pressure, and insomnia. Patients who are sensitive to caffeine or already experiencing cardiovascular side effects may want to reduce or limit caffeine intake while on Sunosi.

The Bottom Line

Staying safe on solriamfetol (Sunosi) requires more than just taking the right dose. Avoiding MAO inhibitors, excess caffeine, sympathomimetic drugs, and poor timing habits is essential for the medication to work without adding unnecessary risk. Certain patient groups, including those with heart conditions, renal impairment, or a history of substance use, face a higher baseline risk that deserves a personalized review. Doctronic has conducted over 22 million AI consultations and offers free AI consultations and $39 video visits available 24/7, making it easy to get a thorough medication safety check before or during treatment. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.